Why is the formula your patients get from WIC changing?

The WIC program is required to have a contract with a specific formula company to help keep costs down. There are separate contracts for milk-based and soy-based formulas. We renew these contracts every five years. The award for the contract from October 2022 – September 2027 for milk-based formula is Mead Johnson, the makers of Enfamil.

The milk-based formulas offered under the new contract include:

  • Enfamil Infant
  • Enfamil Gentlease
  • Enfamil A.R.
  • Enfamil Reguline

The soy-based formula will continue to be with Abbott, the makers of Similac.

This website uses cookies to offer you a better browsing experience. If you continue to use this website, you consent to our use of cookies. Please note some cookies are required for the function of the course. To learn more please read our Privacy Policy.

Copyright ©SPCAA WIC Designed by DSBWorldWide, Inc. Powered by WebItems® Software.